Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder

NCT05525637 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1041

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia Disorder

Interventions

DRUG: YZJ-1139 20mg
DRUG: YZJ-1139 40mg
DRUG: Placebo

Sponsor

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.